CRYSTALLINE FORM OF 1 ,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1 ,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1 ,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT
Lai, Chiajen,Yu, Lok Him Lawrence,Yu, Richard Hung Chiu,De Armas, Hector Novoa
申请号：
AU2019283825
公开号：
AU2019283825A1
申请日:
2019.12.17
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2019283825A120200116.pdf#####C: Interoven NRPortbl DCC SXD 19617793_1.docx-16/12/2019 ABSTRACT (0 N Ph - o S " N N N 0 N H 0 N (Ia)Ph The invention provides a crystalline form of the compound of formula (la), methods for making the crystalline form of the compound of formula (la), and therapeutic methods for the use of the crystal line form of the compound of formula (la).
